Dolby Labs Has Easy 30% Upside

10:21am, Monday, 06'th Apr 2026
Dolby Laboratories (DLB) offers a compelling risk-reward profile with high margins, robust free cash flow, and a reasonable valuation. DLB's intrinsic value is estimated near $80 per share, implying 3
Dolby Laboratories (NYSE: DLB - Get Free Report) has been assigned an average rating of "Moderate Buy" from the five brokerages that are currently covering the company, MarketBeat reports. Two researc
Dolby Laboratories (NYSE: DLB - Get Free Report) shares reached a new 52-week low during mid-day trading on Thursday. The company traded as low as $58.13 and last traded at $58.6210, with a volume of
Dolby Vision 2 recognized in the Consumer Electronics category as a revolutionary leap forward for picture quality SAN FRANCISCO, March 24, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB) i
New analyses show DLB patients with lower plasma pTau181 levels — indicating an earlier stage of disease and absence of Alzheimer's disease (AD) co-pathology — experienced greater clinical benefit
Investments in cutting-edge and innovative solutions are likely to aid Zacks Audio Video Production industry participants like DLB, SONO and LVO amid cautious discretionary spending.
ACEL, CROX, ALTO and DLB gain appeal as easing inflation boosts rate-cut hopes and earnings estimates climb for these consumer discretionary picks.
Dynamic Technology Lab Private Ltd reduced its position in shares of Dolby Laboratories (NYSE: DLB) by 79.5% in the undefined quarter, according to the company in its most recent Form 13F filing with
We believe regulatory strategy expedites development of potential first treatment to address DLB psychosis We believe regulatory strategy expedites development of potential first treatment to address
Consumer confidence rebounds as inflation fears ease, spotlighting RSI, CROX, CALY, DLB and MCFT on upbeat earnings revisions.
Envestnet Asset Management Inc. decreased its holdings in shares of Dolby Laboratories (NYSE: DLB) by 9.9% in the undefined quarter, according to the company in its most recent Form 13F filing with th
The average of price targets set by Wall Street analysts indicates a potential upside of 40.2% in Dolby Laboratories (DLB). While the effectiveness of this highly sought-after metric is questionable,
Cooling inflation and rising spending lift CCL, CALY, DLB and MAR as earnings estimates climb and growth outlooks brighten.
Neo Ivy Capital Management acquired 117,964 shares of DLB in the fourth quarter. The quarter-end stake value increased by $7.58 million due to the new shares acquired.
Consumer sentiment hits 6-month high as inflation hopes rise, spotlighting CCL, DLB, MAR and RL with upbeat earnings revisions on rate-cut optimism.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE